News
The American Cancer Society (ACS) today announced a new partnership with Guardant Health (Nasdaq: GH), a leading precision ...
StockStory.org on MSN19h
RadNet (RDNT) Reports Q2: Everything You Need To Know Ahead Of EarningsDiagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results next tomorrow after market close. Here’s ...
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
1d
Investor's Business Daily on MSNStocks Showing Market Leadership: Guardant Health Earns 92 RS RatingGuardant Health earns the No. 12 rank among its peers in the Medical-Services industry group. GeneDx Holdings WGS, Hims & Hers Health HIMS and Stevanato Group STVN are among the top 5 highly rated ...
Actor James Van Der Beek has been so open, honest, and vulnerable about his journey with colorectal cancer after revealing ...
2don MSN
James Van Der Beek is sharing the subtle colorectal cancer symptom he ignored before his shocking diagnosis. “There wasn’t ...
Exact Sciences is paying $75 million for exclusive rights to a blood-based "liquid biopsy" screening test from rival firm ...
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth ...
James Van Der Beek has just woken up from a nap as he hops on a Microsoft Teams call.
HealthDay News — Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within 6 months, according to a study ...
A groundbreaking study reveals that Guardant Reveal's liquid biopsy detects immunotherapy responses earlier, enhancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results